GlycoEra leverages its control over natural glycan-mediated pathways to advance novel drugs using its proprietary platform, the CustumGlycan Platform. GlycoEra develops first in class therapeutics in inflammatory disease, autoimmune disorder and immuno-oncology indications.
- https://glycoera.com/
- +41 44 244 95 95
- Send an email
- Dominique Nicolas Sirena